Cited by 7Hepatitis B Virus StudiesLiver physiology and pathologyHepatitis C virus research

Potential role of liver-resident CD3+ macrophages in HBV clearance in a mouse hepatitis B model

Open access
Wang, Cong, Zai, Wenjing, Zhao, Kuangjie, Li, Yaming, Shi, Bisheng, Wu, Min, Zhou, Xiaohui, Kozlowski, Maya +3 more·2025·JHEP Reports

Abstract

Background & Aims Chronic HBV infection usually causes cirrhosis and hepatocellular carcinoma. Comparative investigations of acute and chronic HBV cases would help determine the immune responses crucial for viral clearance. Methods A fast-cleared HBV mouse model was established in Alb-Cre mice via hydrodynamic injection of HBV plasmid, while persistent HBV model mice were generated via recombinant covalently closed circular DNA-adeno-associated virus 8 infection. The single-cell transcriptomes of CD45 + intrahepatic non-parenchymal cells from these mice were conducted. Multiplexed immunohistochemistry and flow cytometry were used to confirm the findings from single-cell transcriptomes. Transwell, coculture, and adoptive transfer experiments were performed to study the generation and functions of macrophages. Results Twenty-four clusters of immune cells were identified. Myeloid cells, including granulocytes, monocytes, and dendritic cells, are activated early in HBV fast-cleared mice. Significantly, a cluster of CD3 + macrophages was found in the viral clearance phase, which was confirmed in liver tissue from five acute patients with HBV. These cells highly expressed CXCL1, tumor necrosis factor alpha, and HBsAg-specific T cell receptors. The transwell assay revealed that CD3 + macrophages originate from macrophages (n = 6). T cells and anti-HBsAg antibodies are indispensable for their differentiation, which was further confirmed in T- and/or B-cell-deficient mice. Interestingly, these CD3 + macrophages capable of killing peptide-loaded hepatocytes and engulfing IgG-coated beads were persistently detectable in the mouse liver for 10 weeks after HBV clearance. The expression levels of CD5L and Bcl2, two classical antiapoptotic proteins, increased ( p <0.001), suggesting that the CD3 + macrophages are long-term resident populations. Finally, adoptive transfer of CD3 + macrophages accelerated HBV clearance in mice (n = 5, p <0.01). Conclusions We identified long-term polyfunctional CD3 + macrophages residing in HBV fast-cleared livers that could help elucidate the immune responses involved in eliminating HBV. Impact and implications The liver is a special organ with unique immune characteristics and tolerance to foodborne antigens. Chronic infections can develop in newborns after exposure to HBV; however, acute infections usually occur in adults, indicating that immune cells in the liver tissue microenvironment can also effectively fight against the virus. Nevertheless, the mechanisms involved in acute HBV infection have rarely been studied. In this study, we identified a macrophage population with both T cell and macrophage characteristics in the livers of acute HBV model mice and revealed that these macrophages play important roles in HBV clearance. Moreover, we confirmed that this population is derived from macrophages in the presence of virus-specific T cells and antibodies. This finding highlights the complexity of antiviral immune responses in liver microenvironments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhepr.2024.101323

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 53 · Cited by 7

Research works printed but not linked: 49

  1. [1]Tan M. Bhadoria A.S. Cui F. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis Lancet Gastroenterol Hepatol 6 2021 106 119 33197397 PMC7801814
  2. [2]Liaw Y.F. Chu C.M. Hepatitis B virus infection Lancet 373 2009 582 592 19217993
  3. [3]Ott J.J. Stevens G.A. Groeger J. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity Vaccine 30 2012 2212 2219 22273662
  4. [4]Fang Z. Zhang Y. Zhu Z. Monocytic MDSCs homing to thymus contribute to age-related CD8+ T cell tolerance of HBV J Exp Med 219 2022 e20211838 PMC8906470 35254403
  5. [5]Li H. Yan L. Shi Y. Hepatitis B virus infection: overview Adv Exp Med Biol 1179 2020 1 16 31741331
  6. [6]Gao B. Basic liver immunology Cell Mol Immunol 13 2016 265 266 27041634 PMC4856812
  7. [7]Heymann F. Tacke F. Immunology in the liver – from homeostasis to disease Nat Rev Gastroenterol Hepatol 13 2016 88 110 26758786
  8. [8]Robinson M.W. Harmon C. O'Farrelly C. Liver immunology and its role in inflammation and homeostasis Cel Mol Immunol 13 2016 267 276 PMC4856809 27063467
  9. [9]Jovic D. Liang X. Zeng H. Single-cell RNA sequencing technologies and applications: a brief overview Clin Transl Med 12 2022 e694 35352511 PMC8964935
  10. [10]Wen L. Li G. Huang T. Single-cell technologies: from research to application Innovation (Camb) 3 2022 100342 PMC9637996 36353677
  11. [11]Shen Z. Yang H. Yang S. Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance Nat Commun 8 2017 2119 29242561 PMC5730569
  12. [12]Wu M. Wang C. Shi B. A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia Antivir Res 180 2020 104826 32502604
  13. [13]Ulbrich J. Lopez-Salmeron V. Gerrard I. BD Rhapsody™ Single-Cell Analysis System Workflow: from sample to multimodal single-cell sequencing data Methods Mol Biol 2584 2023 29 56 36495444
  14. [14]Salcher S. Heidegger I. Untergasser G. Comparative analysis of 10X Chromium vs. BD Rhapsody whole transcriptome single-cell sequencing technologies in complex human tissues Heliyon 10 2024 e28358 PMC11059509 38689972
  15. [15]Froh M. Konno A. Thurman R.G. Isolation of liver Kupffer cells Curr Protoc Toxicol 14 2003 Unit14 14 23045093
  16. [16]Wu J.E. Manne S. Ngiow S.F. In vitro modeling of CD8(+) T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40 Sci Immunol 8 2023 eade3369 PMC11975459 37595022
  17. [17]Cao W. Sturmlechner I. Zhang H. TRIB2 safeguards naive T cell homeostasis during aging Cell Rep 42 2023 112195 PMC10118747 36884349
  18. [18]Zhang J. Patel J.M. Role of the CX3CL1-CX3CR1 axis in chronic inflammatory lung diseases Int J Clin Exp Med 3 2010 233 244 20827321 PMC2929949
  19. [19]Chaudhary N. Jayaraman A. Reinhardt C. A single-cell lung atlas of complement genes identifies the mesothelium and epithelium as prominent sources of extrahepatic complement proteins Mucosal Immunol 15 2022 927 939 35672453 PMC9173662
  20. [20]Horowitz A. Yu H. Pandey S. C1QA is an invariant biomarker for tissue macrophages Preprint) bioRxiv 2024 10.1101/2024.01.26.577475 · DOI
  21. [21]Bility M.T. Cheng L. Zhang Z. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages Plos Pathog 10 2014 e1004032 PMC3961374 24651854
  22. [22]Sade-Feldman M. Kanterman J. Ish-Shalom E. Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation Immunity 38 2013 541 554 23477736
  23. [24]Chavez-Galan L. Olleros M.L. Vesin D. Much more than M1 and M2 macrophages, there are also CD169(+) and TCR+ macrophages Front Immunol 6 2015 253 26074923 PMC4443739
  24. [25]Beham A.W. Puellmann K. Laird R. A TNF-regulated recombinatorial macrophage immune receptor implicated in granuloma formation in tuberculosis Plos Pathog 7 2011 e1002375 PMC3219713 22114556
  25. [26]Chavez-Galan L. Vesin D. Blaser G. Myeloid cell TNFR1 signaling dependent liver injury and inflammation upon BCG infection Sci Rep 9 2019 5297 30923339 PMC6438980
  26. [27]Pallett L.J. Swadling L. Diniz M. Tissue CD14(+)CD8(+) T cells reprogrammed by myeloid cells and modulated by LPS Nature 614 2023 334 342 36697826 PMC7619353
  27. [28]Oakley M.S. Chorazeczewski J.K. Aleshnick M. TCRβ -expressing macrophages induced by a pathogenic murine malaria correlate with parasite burden and enhanced phagocytic activity PLoS One 13 2018 e0201043 PMC6059462 30044851
  28. [29]Zhao J. Zhang S. Liu Y. Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human Cell Discov 6 2020 22 32351704 PMC7186229
  29. [30]Zhang C. Li J. Cheng Y. Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients Gut 72 2023 153 167 35361683 PMC9763233
  30. [31]MacParland S.A. Liu J.C. Ma X.Z. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations Nat Commun 9 2018 4383 30348985 PMC6197289
  31. [32]Fred R.G. Steen Pedersen J. Thompson J.J. Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis Sci Rep 12 2022 13484 PMC9355943 35931712
  32. [33]Hoogeveen R.C. Robidoux M.P. Schwarz T. Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection Gut 68 2019 893 904 30580250
  33. [34]Maini M.K. Boni C. Ogg G.S. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection Gastroenterology 117 1999 1386 1396 10579980
  34. [35]Thimme R. Wieland S. Steiger C. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection J Virol 77 2003 68 76 12477811 PMC140637
  35. [36]Wu L.L. Peng W.H. Wu H.L. Lymphocyte antigen 6 complex, locus C(+) monocytes and Kupffer cells orchestrate liver immune responses against hepatitis B virus in mice Hepatology 69 2019 2364 2380 30661248
  36. [37]De Simone G. Andreata F. Bleriot C. Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming Immunity 54 2021 2089 100.e2088 34469774 PMC8459394
  37. [38]Rodriguez-Cruz A. Vesin D. Ramon-Luing L. CD3(+) macrophages deliver proinflammatory cytokines by a CD3-and transmembrane TNF-dependent pathway and are increased at the BCG-infection site Front Immunol 10 2019 2550 31787969 PMC6855269
  38. [39]Alvarez-Errico D. Vento-Tormo R. Sieweke M. Epigenetic control of myeloid cell differentiation, identity and function Nat Rev Immunol 15 2015 7 17 25534619
  39. [40]Arneth B. Trained innate immunity Immunol Res 69 2021 1 7 33454874
  40. [41]Kleinnijenhuis J. Quintin J. Preijers F. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes Proc Natl Acad Sci U S A 109 2012 17537 17542 22988082 PMC3491454
  41. [42]Mata E. Tarancon R. Guerrero C. Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis Sci Immunol 6 2021 eabc2934 34559551
  42. [43]Zhang N. Hartig H. Dzhagalov I. The role of apoptosis in the development and function of T lymphocytes Cell Res 15 2005 749 769 16246265
  43. [44]Sanchez-Moral L. Rafols N. Martori C. Multifaceted roles of CD5L in infectious and sterile inflammation Int J Mol Sci 22 2021 4076 33920819 PMC8071174
  44. [45]Sanjurjo L. Aran G. Tellez E. CD5L promotes M2 macrophage polarization through autophagy-mediated upregulation of ID3 Front Immunol 9 2018 480 29593730 PMC5858086
  45. [46]Sanjurjo L. Aran G. Roher N. AIM/CD5L: a key protein in the control of immune homeostasis and inflammatory disease J Leukoc Biol 98 2015 173 184 26048980
  46. [47]Kim T.H. Yang K. Kim M. Apoptosis inhibitor of macrophage (AIM) contributes to IL-10-induced anti-inflammatory response through inhibition of inflammasome activation Cell Death Dis 12 2021 19 33414479 PMC7791024
  47. [48]Irabu H. Shimizu M. Kaneko S. Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Schonlein purpura nephritis Pediatr Res 89 2021 667 672 32408340
  48. [49]Fuchs T. Hahn M. Riabov V. A combinatorial αβ T cell receptor expressed by macrophages in the tumor microenvironment Immunobiology 222 2017 39 44 26494401
  49. [50]Jiang Y. Zhang S. Tang L. Single-cell RNA sequencing reveals TCR(+) macrophages in HPV-related head and neck squamous cell carcinoma Front Immunol 13 2022 1030222 PMC9647120 36389736

Authors
Wang, C., Zai, W., Zhao, K., Li, Y., Shi, B., Wu, M., Zhou, X., Kozlowski, M., Zhang, X., Fang, Z., & Yuan, Z.
Affiliations
  • Shanghai Medical College of Fudan University (CN)
  • Fudan University (CN)
Corresponding author
  • Fang, Zhong
  • Yuan, Zhenghong
Venue
JHEP Reports
Publisher
Elsevier BV
Published
2025-04
Volume
7
Issue
4
Pages
101323
ISSN
2589-5559 (ISSN-L)
OpenAlex
W4405941708
Cited by
7
References
53
Citations by year
2026: 5 · 2025: 2
FWCI
2.14
Type
journal article
Language
en
Open access
Locations
  • JHEP Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Science and Technology Commission of Shanghai Municipality (ZD2021CY001)
  • National Key Research and Development Program of China (2021YFC2300602)
  • National Natural Science Foundation of China (U23A20474, 91842309)
Topics
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Keywords
hepatitis B virus, HBV clearance, anti-HBsAg antibodies, T cell help, adoptive transfer, macrophage origin, CD5L, Bcl-2, single-cell transcriptomics, AAV8

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review